🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of acetaminophen, asserting the corporations concealed alleged dangers that the pain reliever posed to pediatric cognitive development.

The lawsuit arrives a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - referred to as paracetamol - throughout gestation and autism in offspring.

The attorney general is filing suit against Johnson & Johnson, which once produced the medication, the only pain reliever approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a statement, he stated they "betrayed America by gaining financially from pain and marketing drugs regardless of the potential hazards."

The company says there is no credible evidence connecting Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening numerous people to boost earnings," the attorney general, a Republican, stated.

The manufacturer commented that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the welfare of American women and children."

On its website, the company also said it had "regularly reviewed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between using paracetamol and autism."

Groups representing doctors and medical practitioners agree.

The leading OB-GYN organization has stated acetaminophen - the primary component in Tylenol - is one of the few options for expectant mothers to address discomfort and fever, which can pose major wellness concerns if ignored.

"In more than two decades of studies on the utilization of paracetamol in gestation, no reliable research has successfully concluded that the usage of acetaminophen in any stage of pregnancy causes brain development issues in children," the group said.

The court filing mentions current declarations from the previous government in claiming the drug is allegedly unsafe.

Recently, Trump generated worry from medical authorities when he instructed pregnant women to "resist strongly" not to take acetaminophen when sick.

The FDA then released a statement that physicians should think about restricting the usage of Tylenol, while also stating that "a causal relationship" between the medication and autism in minors has not been proven.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had pledged in spring to initiate "comprehensive study program" that would identify the source of autism in a matter of months.

But specialists advised that discovering a sole reason of autism - believed by scientists to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that impacts how individuals perceive and relate to the environment, and is diagnosed using doctors' observations.

In his court filing, Paxton - aligned with the former president who is seeking US Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the research" around paracetamol and autism.

This legal action attempts to require the firms "destroy any commercial messaging" that asserts acetaminophen is reliable for women during pregnancy.

The Texas lawsuit parallels the complaints of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in two years ago.

The court dismissed the legal action, declaring research from the family's specialists was not conclusive.